View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Uncategorised
March 2, 2021

Coronavirus company news summary – Eurofins announced launch of at-home PCR test kit for Covid-19 – FDA grants emergency use authorisation for home collection kit

By Chloe Kent

Eurofins Clinical Enterprise has been granted Emergency Use Authorization (EUA) by the US Food and Drug Administration (FDA) for an updated version of its direct-to-consumer (DTC) empowerDX home Covid-19 collection kit. Eurofins’ Covid-19 home nasal PCR kit is directly available to US customers, without prescription, both online and at drug stores in the US.

Fluidigm Corporation has been granted EUA by the FDA for the AZOVA Covid-19 test collection kit, for use with the Fluidigm Advanta Dx SARS-CoV-2 RT-PCR assay on the company’s Biomark HD platform. The kit is authorised for at-home self-collection through prescription only, for individuals suspected to be suffering with Covid-19 symptoms.

Mobidiag has been granted CE-IVD marking for its Amplidiag RESP-4 molecular diagnostic test for the rapid and combined detection of prevalent respiratory viruses such as SARS-CoV-2 virus, Influenza A, Influenza B and respiratory syncytial virus (RSV).

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Medical Device Network